Individual patient data meta-analyses using the raw data from primary diagnostic accuracy studies are taking hold in systematic reviews evaluating tests. Conventional reviews and meta-analyses that summarise study-level data on test accuracy (sensitivity and specificity) have several disadvantages.
Introduction
Individual patient data meta-analyses may be defined as the calculation of a summary across primary empirical studies using the raw data collected in those studies. 1 In meta-analyses of randomised trials this approach is considered the 'gold' standard for the following reasons [2] [3] [4] : First, in as far as the published reports of studies may lack full description of important details, access to their protocols enhances judgements about their exact methods. These insights may well have consequences for the meta-analysis. Second, the raw data enable the meta-analysts to perform standardised consistency checks on aspects of the data that (some of ) the primary investigators may have omitted. Third, possibly unnecessary omissions of certain patients from the published analyses may be corrected, thus minimising the risk of bias. Fourth, different data-analytic approaches between the primary studies, which often hamper the calculation of meta-analytic summary measures based on published work, can be overcome. For example, uniform cut points for variables or outcome phenomena may be chosen. Access to complete datasets, with the sample size thus increased, gives greater flexibility to perform powerful analyses, particularly in subgroups.
Why should meta-analysis using raw data be more valuable than meta-analysis based on aggregated data reported in diagnostic research? In this article we explore the extent to which the aforementioned advantages translate, and what the particular challenges and opportunities are in research evaluating tests.
Diagnostic accuracy studies: their scope and their limitations Over the past decades, the two-by-two contingency table (cross-classifying a test using a threshold first in positive and negative results, and then in true and false positives and negatives against a gold standard) features as a cornerstone of diagnostic methodology. 5 6 These concepts are ancient. Epictetus (55-135 ad), a Greek philosopher, is said to have described in second century:
Things either are what they appear to be (true positive); or they neither are not appear to be (true negative); or they are and do not appear to be (false negatives); or they are not, yet appear to be (false positive). Estimation of accuracy in form of sensitivity and specificity follows from these data. These estimates are frequently misunderstood by clinicians. 7 A little consideration makes it obvious that these concepts are not easy to apply in clinical diagnosis. In practice most tests have (many) more than two possible test results. Moreover, a realistic diagnostic work-up consists of a chain of interlinked items derived from demographics, pieces of the clinical history and physical examination and possibly several tests (laboratory, imaging and other technologies). In these situations, the diagnostic problem just cannot be reduced to a two-by-two table. Primary studies and meta-analyses that summarise study-level data on test accuracy usually estimate the rates of test result-given disease (sensitivity is probability of positive test result-given disease is present; and specificity is probability of negative test result-given disease is absent). This is a fundamental limitation and it may be addressed by summarising predictive values. 8 However, estimating accuracy for individual tests without consideration of other tests in the test chains that make up everyday diagnostic work-ups remain a problem. To deal with the need to consider multiple tests in problem solving, the likelihood ratio (LR, also derived from the two-by-two table) has gained popularity as a means of generating post-test probabilities (Bayes' rule, enshrined in Fagan's nomogram). 9 The simple use of this approach where the probability generated serves as pre-next-test probability in a test chain, fails to take into account the overlap that exists between tests. Two-by-two tables may sometimes work fine in situations like mass screening where a single test with two possible results will be used for public health. Test evaluation studies comparing multiple tests with a reference standard, 10 address uncertainty about the value of two competing alternatives. In clinical practice, by far the commonest situation is that practitioners use a series of tests for making diagnosis and this paper focuses on the use of multivariable models to determine which available tests should be combined and how. Take a scenario where a clinician would like to know the probability that a woman has endometrial cancer based on the results of commonly used series of diagnostic tests. Clinical history items are included in the series as tests. To obtain these estimates LRs can be obtained for individual tests and Bayes theorem applied. The repeated application of the theorem as one moves from one test to the other produces biased inferences 11 as shown in figure 1 . This approach assumes independence between information coming from different tests conditional on disease status, that is, if one test makes an error in a patient, it does not increase the likelihood of another test making an error. Ideally post-test probabilities should be derived from multivariate analyses of primary data taking into account mutual dependencies between test results. The advantages of tackling diagnostic problems in a logistic regression framework have been known for some time, originating in a landmark paper by Dawid. 12 These models allow a direct estimation of the post-test (-chain) disease probabilities. 13 14 To do this with a reasonable degree of precision requires large study samples which are generally infeasible or unavailable in primary literature. 15 Successful individual patient data metaanalyses create the opportunity to calculate directly and reliably disease probabilities corresponding with realistic chains of tests, thereby making outputs of reviews of test accuracy clinically applicable. It is these predictive probabilities that the clinician wants, making any preoccupation with sensitivity, specificity, LRs, Bayes' theoram or Fagan's nomogram unnecessary.
Individual patient data meta-analysis of diagnostic studies: its scope and its limitations Individual patient data meta-analyses using the raw data from primary diagnostic accuracy studies are taking hold in systematic reviews evaluating tests. [16] [17] [18] [19] Table 1 summarises our overview of issues in meta-analyses of diagnostic test accuracy studies. In practice, the major challenge is not so much analytical, but winning over the investigators, who carried out the primary to provide the meta-analysts with their raw data. In this respect, mutual trust and esteem, and publication as a collaborative group are the key issues. Systematic reviewers face huge problems in judging basic (validity) aspects of the underlying of diagnostic accuracy studies. Deeks stated that "(…) meta-analyses of diagnostic test accuracy studies are hindered by a lack of appreciation and knowledge of the important aspects of study design, poor standards of reporting and publication bias." 20 Obviously, all sophisticated metaanalytic techniques rely on validity of study methods. Similar to individual patient data meta-analysis of randomised trials, for diagnostic studies too, access to study protocols and primary investigators in a collaborative setting is likely to improve insight in the true study procedures. When the diagnostic meta-analysis is planned to involve multivariable modelling, the challenges faced are similar to those in prognostic research. 21 22 A pleasant feature of the multivariable model output is that it supplies us with the very thing clinicians are after, namely the probability of disease presence given a Figure 1 Post-test-chain probabilities after four tests contrasting a simple approach assuming independence between test results (solid line) to an approach based on a logistic regression model that takes into account overlap of information between tests (dottled line). Note the almost 20% overestimation by the simple approach. Reproduced with permission based on Bachmann et al.
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sequence of test results. Unlike the application of logistic regression in aetiological research, the investigator and reader should not focus on the separate ORs for the different test categories, but instead focus on the distribution of the disease probabilities directly. The theoretically optimal and clinically most attractive result is the correct assignment-after all test results are known-of either a disease probability of 1 or 0 to each patient suspected of the target disease. In reality, of course many results between these extremes are observed. The ideal situation in which all patients underwent all tests in the chain of tests making up a complete work-up allows the determination of the optimal sequence of tests. What are the limitations of diagnostic individual patient data meta-analysis? In general, this approach cannot repair flaws in designs of diagnostic studies owing to inappropriate patient sampling, use of imperfect reference standard or missing information on reference standard. These meta-analyses heavily rely on capturing the bulk of the available valid data. A conventional metaanalysis is a good starting point for any individual patient data meta-analysis. If the meta-analysts do not succeed in obtaining the large majority of valid studies, some of the data-analytic advantages may disappear, depending partly on how selective data are 'missing'. Good judgements about the latter aspect are often difficult to make.
The most fundamental assumption in the proposed individual patient data meta-analysis is that it captures patient-specific data on more than one test making up a realistic work-up. It may well be that that investigators of primary studies did not report on all relevant tests in their published papers. However, their data files may contain information on demographics, clinical history and, perhaps, other tests which they did not report. To assume that all test procedures are truly the same procedure technically across studies is hazardous. Raw data meta-analysts would be in an ideal position to analyse potential differences in diagnostic prediction associated with specific characteristics of a particular procedure possibly suggesting the best way to carry out the procedure. For example, endometrial ultrasound may be reported with features like thickness, regularity or fluid. Finally, missing data may be a problem if, for some reason, in too many women some tests were omitted. In this respect, missing data on the final diagnosis are of special concern. Input from statisticians is necessary and the proper handling of missing data in diagnostic meta-analyses warrant further research.
Let us revert back to the example of endometrial cancer diagnosis in figure 1 . Having performed extensive literature-based reviews without language restrictions (updating our previous reviews 23 24 ), we piloted the raw data meta-analysis using the approach described above using individual data from four publications. 11 25-27 The results are shown in table 2 displaying the post-test probabilities and their CI for specific combinations of test Table 1 Comparison between meta-analyses based on data aggregated from published diagnostic studies and those based on individual patient data, in which raw data obtained from the primary investigators are used* Meta-analysis based on aggregated data in published papers Individual-patient-data meta-analysis
Relatively unproblematic applications ▸ Single test situations (mass screening) ▸ Multiple tests that focus on aspects of the target condition that are truly independent pathophysiologically (this should not be assumed lightly)
▸ Access to study protocols ▸ More occurrences of the target events, subject to completeness of data capture, extending the mathematical modelling options (eg, interactions between tests) ▸ Summary measure is a (set of) diagnostic function(s) that allow easy translation into the clinically useful probability of disease given all test results ▸ Quantification of the influence of additional tests in a uniform manner ▸ Determination of optimal test sequence ▸ Given some data on utility judgments and/or costs, formal decision analysis may be performed (eg, using log-linear models to estimate absolute frequencies of test results) 28 29 This approach produces probabilities that are more realistic than those produced with use of simply Bayes' rule. The communication of the probability data can be enhanced by use of natural frequencies. 30 31 The future: prospective individual patient data meta-analysis Meta-analysis using data from individual patients in diagnostic research are in their infancy. However, there is a clear need to explore this approach when-in a realistic test chain-many tests are used to arrive at a diagnosis.
Where single test accuracy studies and comparative diagnostic evaluations have merit, 8 10 it can be beneficial to have access to raw data for meta-analysis for more reliable estimation, particularly in subgroups, and more detailed analysis of thresholds. The main challenge lies in the successful establishment of an international collaborative group centred on a common diagnostic work-up. Once this has been achieved and primary data aggregated in a unique database, analyses produce diagnostic probabilities of disease presence for each possible combination of test results ready for use in daily practice. An important spin-off associated with international collaborations in an individual patient data meta-analysis context may be the concerted planning of new research efforts. Such projects through consultation within the collaboration may lead to ways of data collection that greatly facilitates later raw data meta-analyses. In this respect prospectively planned individual patient data diagnostic meta-analyses should be an aspiration for future research. Another important issue is the development of easy-to-use reporting formats for end-users. Tables like table 2 are useful, though with many tests to consider the reading of tables could be cumbersome. Hand-held or online calculators that hide the mathematical model are a possible way forward. 32 33 Competing interests None. 
